Amplitude Surgical announces the closing of the sale of Novastep's activities
29 Junio 2023 - 1:00AM
Business Wire
Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible
for PEA-PME savings plans), a leading French player on the surgical
technology market for lower-limb orthopedics, announces the closing
of the sale of the entire Novastep business, specializing in
extremity surgery (feet and ankles) to Enovis Corporation.
The sale will generate approximately 68 million euros for
Amplitude. In the next few days, Amplitude will use part of this
amount to proceed with the partial early redemption of 40 million
euros of the 110 million euros bond issued on November 10,
2020.
Next press release:
2022-23 full-year sales, on Thursday July 20, 2023, after
market.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a
leading French player on the global surgical technology market for
lower-limb orthopedics. Amplitude Surgical develops and markets
high-end products for orthopedic surgery covering the main
disorders affecting the hip and knee. Amplitude Surgical develops,
in close collaboration with surgeons, numerous high value-added
innovations in order to best meet the needs of patients, surgeons
and healthcare facilities. A leading player in France, Amplitude
Surgical is developing abroad through its subsidiaries and a
network of exclusive distributors and agents distributing its
products in more than 30 countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230628359537/en/
Amplitude Surgical CFO Dimitri Borchtch
finances@amplitude-surgical.com +33 (0)4 75 41 87 41
NewCap Investor Relations Thomas Grojean
amplitude@newcap.eu +33 (0)1 44 71 94 94
NewCap Media Relations Nicolas Merigeau
amplitude@newcap.eu +33 (0)1 44 71 94 98
Amplitude Surgical (EU:AMPLI)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
Amplitude Surgical (EU:AMPLI)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025
